Advances in gene therapy for mitochondrial genetic disorders: current status and clinical implementation challenges
Lei Lyu, Beibei Qie, Yanjie He, Feilong Chen, Bao Liu · 2025
Read Advances in gene therapy for mitochondrial genetic disorders: current status and clinical implementation challenges by Lei Lyu, Beibei Qie, Yanjie He, Feilong Chen, Bao Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729811.txt.
Description
Lei Lyu and co-authors review progress and roadblocks in gene therapy for diseases caused by faulty mitochondrial DNA. These mutations can bring severe illness or early death. Mitochondria carry their own small genome inside cells.
Three broad strategies dominate the field today. One expresses the gene from the nucleus instead. Others cut faulty copies with targeted nucleases. Base editing rewrites single letters of the mitochondrial code. Mixed copies inside one cell complicate every approach. Delivery across mitochondrial membranes adds another hurdle. The review weighs clinical gains against preclinical promise. It points to fixes that could unlock wider use in clinics soon for the sick who wait.
Catalog record
| CREATOR | Lei Lyu, Beibei Qie, Yanjie He, Feilong Chen, Bao Liu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 133 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |